Deferasirox Tablet, Film Coated
Product Images NDC 59651-412

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 59651-412). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Deferasirox Fig1)

A bar graph showing changes in liver iron concentration and serum ferritin levels following Deferrasirox tablets for oral suspension at doses ranging from 5 to 30 mg/kg/day. The x-axis represents dose levels, and the y-axes show changes in liver iron content in mg Fe/g dry weight and serum ferritin in mcg/L. Bars indicate mean changes for both parameters across different sample sizes per dose group.*

FDA Label Image

Package Label-principal Display Panel (90 mg (30 Tablet Bottle))

Label for Deferasirox Tablets 90 mg, film-coated oral tablets by Aurobindo Pharma Limited. The label states the NDC 59651-410-30 and package contains 30 tablets. It includes storage instructions, distributor information (Aurobindo Pharma USA, Inc.), and a website link for medication guides. The tablets contain 90 mg of deferasirox each.*

FDA Label Image

Package Label-principal Display Panel (180 mg (30 Tablet Bottle))

Label for Deferasirox Tablets 180 mg film-coated oral tablets by Aurobindo Pharma Limited. The label shows a 30-tablet package with directions to see the package insert for dosage, storage instructions at 20° to 25°C, and a barcode. Distributed by Aurobindo Pharma USA, Inc., made in India.*

FDA Label Image

Package Label-principal Display Panel (360 mg (30 Tablet Bottle))

Label for Deferasirox Tablets 360 mg, film-coated oral tablets by Aurobindo Pharma Limited. The label states the NDC number 59651-412-30 and indicates a package size of 30 tablets. It includes storage instructions, dispensing guidance, and distributor information for Aurobindo Pharma USA, Inc. Made in India.*

FDA Label Image

Chemical Structure (Deferasirox Str)

Chemical structure diagram of Deferasirox, showing its molecular arrangement with three aromatic rings including hydroxyl (OH) and carbonyl (C=O) functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.